We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 198,696 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.40 | 1.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/2/2018 11:54 | Bring on a quid please! GLa and DYOR | qs99 | |
13/2/2018 11:54 | Looking pretty good for a "quiet day" | urigem | |
13/2/2018 11:51 | Wow! 32 p and rising | jamdan1 | |
13/2/2018 11:49 | Looking that way | urigem | |
13/2/2018 11:48 | into the 30s now | falia | |
13/2/2018 11:43 | One important factor in the context of future collaborations and high value licenses is that NT really emphasises the point in his November presentation that Nuvec is easy to manufacture. | nick2412 | |
13/2/2018 11:41 | Code1 ??????? | ch1rp | |
13/2/2018 11:34 | Kicked back from 30p bid, need another go | urigem | |
13/2/2018 11:19 | Could be a good day today, got leg's longer than Kate moss | urigem | |
13/2/2018 11:18 | There goes 30p...let’s hope it can hold this time ... | jakleeds | |
13/2/2018 11:18 | Jim / always a possibility, but I feel this is a very genuine opportunity. Not a one trick pony! I really like the look of N4P and I do think the tech will work, purely because of its complicated simplicity ?!? But these subject are not for the layman. My only criticism would be the route to market in the investor presentation is a little to simplistic - phase 1 - followed by deal within 6month - easy! but these guys really appear to be in the ball- plus 20% holding for the founder is a big incentive. | urigem | |
13/2/2018 11:15 | No stock about ... | jakleeds | |
13/2/2018 11:04 | Urigem, Good Post above. Careful though, you did mention there us a possibility that nuvec is worth nothing. That will make you unpopular with the rose tinted posters. You'll be called a deramper. | jimbobaroony | |
13/2/2018 11:04 | Off we go again! There are some very determined buyers at the moment.Now let's see if we can break through the previous intra-day high later today. Think that was around 31.5p last Monday. | parob | |
13/2/2018 11:03 | 30p coming up | falia | |
13/2/2018 10:49 | Will we have a pop at 30p today? I think so | urigem | |
13/2/2018 10:47 | My favourite colour | urigem | |
13/2/2018 10:46 | and we are blue | falia | |
13/2/2018 10:40 | Where's Mr Blueeee Fiinnnishhh ? | urigem | |
13/2/2018 09:46 | Hugh - have to start with what we know... If you listened to every CEO on AIM would claimed to be getting widespread deals with nultinationals you would certainly be bankrupt by now. I much more concerned about losing money than making it, and you have to start with confidence in the BOD- big yes so farProducts - big yes so far, simplicity and low risk,high gainProgress - big yes so far, delivered ahead on everything so farHave to remember that this is early stage company and 2-5 year a lot could change for better or worse. But taking that risk into account you still get a multiple. How much Nuvec worthLow end - nothing at all -doesn't workHigh end - world changing patented tech £££££££!So need to put something on it. If this was 100% then Faila's £5 would be considered deramping! | urigem | |
13/2/2018 09:37 | What is your target price Hugh? | eddie_yates | |
13/2/2018 09:25 | Urigem, The value of Nuvec depends on how many deals they sign. How do you even begin to put a value on "WIDESPREAD" deals and collaborations? | hughwilson | |
13/2/2018 09:20 | I think a conservative fair value at this point in time is about 110p. That is putting a 40p share value on Nuvec using Similar Calc's the AIMCHAOS and no added value for the progress made on Viagra. However Nuvec has progressed rapidly over the last few months that it's hard to work out but I feel much more than the current share price on its own | urigem |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions